Sernova Biotherapeutics Inc. SVA.TO
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX · Canada · sernova.com
Sernova Biotherapeutics Inc. is a clinical-stage Canadian regenerative medicine company developing its Cell Pouch bio-hybrid organ system to treat chronic diseases such as Type 1 diabetes. The Cell Pouch creates a vascularized environment enabling transplanted therapeutic cells to survive and function long-term. The company is headquartered in London, Ontario.
Key ratios
ReturnOnAssets TTM -3.77
ReturnOnAssets 2025 -2.26
ReturnOnAssets 2024 -1.34
ReturnOnAssets 2023 -0.68
ReturnOnEquity TTM -7.26
ReturnOnEquity 2023 -1.3